Qure submitted a BLA to FDA and an MAA to the UK's MHRA for ifezuntirgene inilparvovec, based on 3-year phase 1/2 data showing slowed Huntington disease progression. uniQure has submitted a Biologics ...
It'srather well accepted that CTE is associated with cumulative exposure to brain trauma. Therefore, it's reasonable to ...
The updated guideline offers evidence-graded recommendations on when to start migraine prevention, which medications to choose, and how to manage special populations.
New longitudinal functional MRI data, published in Movement Disorders, showed that measurable changes in brain network ...